The company said its product revenues rose during the fourth quarter thanks to an increase in T2Candida panel sales due to increased patient testing.
The funds, which the company said are part of a larger $9 million Series A round, will support the development of its test for early diagnosis of Lyme disease.
T2 said it's in a strong position to achieve planned portfolio milestones over the next two years, including submitting its next test for FDA clearance next year.
The deal gives Oxford access to Imugen’s Lyme disease tests as well as PCR and immunoassay tests.
A PCR-based look at pathogens and parasites in adult Ixodes ricinus ticks from France identified multiple pathogens in more than 20 percent of adult individuals tested.
RNA sequencing uncovered differentially expressed genes in individuals with Lyme disease at diagnosis, immediately after antibiotic treatment, and six months later.
The reference lab noted unusual melt temperatures in samples processed for Lyme disease, and collaborated with others to find the spirochete in Upper Midwest ticks.
Researchers put together an almost 2-billion-base genome assembly for the deer tick, which can transmit pathogens causing Lyme disease and other conditions.
The partnership will combine Aperiomics' data-analysis and bioinformatics technologies with ResourcePath's next-generation sequencing pathogen-testing services.
The funds will support development of a test for detection of multiple tick-borne diseases that Ceres plans to take through the US Food and Drug Administration.
In Science this week: intellectual property landscape of CRISPR genome editing, and more.
A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.
Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.
Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.